ZTSZoetis Inc.

$53B

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.6B+5.2% YoY

Gross Profit

$2.8B62.1% margin

Operating Income

$821M18.0% margin

Net Income

$504M11.1% margin

EPS (Diluted)

$1.01

Cash Flow

Operating Cash Flow

$681M

Free Cash Flow

$497M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$6.6B

Total Liabilities

$5.6B

Stockholders' Equity

$940M

Cash & Equivalents

$610M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.6B	$4.3B	+5.2%
Gross Profit	$2.8B	$2.7B	+4.2%
Operating Income	$821M	$854M	-3.9%
Net Income	$504M	$436M	+15.6%

ZTS FY 2013 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena